Simulations Plus, Inc.

The momentum for this stock is not very good. Simulations Plus, Inc. is not very popular among insiders. Simulations Plus, Inc. may fit well in a Validea momentum strategy portfolio. Simulations Plus, Inc. is a mediocre stock to choose.

Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biote...

News

Wedbush Securities Inc. Buys 1,709 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Zolmax Wedbush Securities Inc. lifted its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 10.5% during the 2nd quarter, according to its most recent 13F filing with the Securities...\n more…

Simulations Plus, Inc. (NASDAQ:SLP) Director Sells $703,600.00 in Stock

Ticker Report Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an...\n more…

Walter S. Woltosz Sells 20,000 Shares of Simulations Plus, Inc. (NASDAQ:SLP) Stock

Zolmax Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction dated Tuesday, September 3rd. The shares were sold at an...\n more…

Maryland State Retirement & Pension System Has $271,000 Stock Position in Simulations Plus, Inc. (NASDAQ:SLP)

Zolmax Maryland State Retirement Pension System decreased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 5.1% during the 2nd quarter, according to the company in its...\n more…

Simulations Plus management to meet with Oppenheimer

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…